Ironshore Pharmaceuticals recognizes ADHD Awareness Month through partnership with CHADD
RESEARCH TRIANGLE PARK, N.C.–(BUSINESS WIRE)–Oct 28, 2019– In recognition of Attention-Deficit/Hyperactivity Disorder (ADHD) Awareness Month, Ironshore Pharmaceuticals Inc. (Ironshore) has partnered with Children and Adults with Attention-Deficit/Hyperactivity Disorder (CHADD) to sponsor an educational webinar to help elevate awareness of ADHD and highlight the…
Caribbean News Editors Choice Education iBusiness iCommunity iHealth iKids iLocal News iWorld News News
Ironshore Pharmaceuticals and CHADD to raise awareness about the negative impact of ADHD during the early morning routine
GEORGE TOWN, Grand Cayman–(BUSINESS WIRE)–Ironshore Pharmaceuticals & Development, Inc. (“Ironshore”), a wholly owned subsidiary of Highland Therapeutics Inc., and Children and Adults with Attention-Deficit/Hyperactivity Disorder (“CHADD”), a national non-profit organization providing education, advocacy and support for individuals with ADHD, today…
